Pharma and profits : (Record no. 33453)

MARC details
000 -LEADER
fixed length control field 01349nam a2200169Ia 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260718102240.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 230508s2022 xx 000 0 und d
050 ## - LIBRARY OF CONGRESS CALL NUMBER
Classification number Allied HD 9666.4
Item number L36 2022
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name LaMattina, John L.
245 10 - TITLE STATEMENT
Title Pharma and profits :
Remainder of title balancing innovation, medicine, and drug prices /
Statement of responsibility, etc. John L. LaMattina.
264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Hoboken, NJ :
Name of producer, publisher, distributor, manufacturer John Wiley & Sons,
Date of production, publication, distribution, manufacture, or copyright notice 2022.
300 ## - PHYSICAL DESCRIPTION
Extent xii, 100 pages ;
Dimensions 23 cm.
500 ## - GENERAL NOTE
General note Includes index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note ch. 1. The $1000 pill: the fiscal consequences of curing hepatitis C — ch. 2. Enter the players: FDA approval does not guarantee commercial success — ch. 3. Pandemic: mRNA vaccine and the race for a cure — ch. 4. Federal investment in r&d: why the government does not deserve a piece of biopharma’s profits? — ch. 5. Inaulin: the true cost of a 100-year-old drug — ch. 6. The costly alzheimer’s disease drug: a questionable breakthrough — ch. 7. Gene therapy: how much a life worth? — ch. 8. Proving the value of expensive drug: should we pay for drugs whose ultimate value is unknown? — cn. 9. Generic drugs: built-in cost controls — ch. 10. About those soaring pharma profits: are they driving healthcare costs? — ch. 11. Schemes to lower drug prices: the impact of reduced resources on r&d.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Books
Call number prefix EAC Cavite-Allied Health Sciences Section
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Cost, normal purchase price Total Checkouts Full call number Barcode Date last seen Copy number Price effective from Koha item type Cost, replacement price
    Library of Congress Classification     EAC Library Cavite EAC Library Cavite EAC Cavite-Allied Health Sciences Section 05/16/2023 2695.50   Allied HD 9666.4 L36 2022 ML16622 05/29/2026 c.1 05/16/2023 Books  
    Library of Congress Classification     EAC Library Cavite EAC Library Cavite EAC Cavite-Allied Health Sciences Section 11/20/2023 2695.50   Allied HD 9666.4 L36 2022 c.2 ML17504 05/29/2026 c2 01/05/2024 Books 2695.50